跳至主要内容
临床试验/NCT03623451
NCT03623451Unknown不适用

Serum Metabolomics Study of Traditional Chinese Medicine Formula (Shen Qi Tiao Ti Formula) Intervention to Polycystic Ovary Syndrome

Heilongjiang University of Chinese Medicine1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2018年8月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
105
试验地点
1
主要终点
The fatty acid amides (FAAs) metabolite changes

研究概览

简要总结

Polycystic ovary syndrome (PCOS) is a most common, heterogeneous, complex endocrinopathy disease.Traditional Chinese medicine (TCM) has been used in the treatment of PCOS for many years. However, the mechanism underlying TCM remains obscure and challenging.In the present study, a metabolomics approach based on ultra-high-performance liquid chromatography (UPLC) coupled with linear ion trap Orbi-trap mass spectrometer (LTQ Orbi-trap MS) is used to investigate serum metabolic changes of TCM intervention to PCOS.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
14 Years 至 40 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • PCOS diagnostic criteria: According to the diagnostic criteria revised by the European Society of Human Reproduction and Embryology and the American Society for Reproductive Medicine at the Rotterdam in 2003, PCOS patients can be diagnosed if two of the three criteria are present after excluding congenial adrenal hyperplasia, Cushing's syndrome, androgen secreting tumors, or other related disorders. The three criteria are (1) oligo- and/or anovulation; (2) clinical and/or biochemical signs of hyperandrogenism (clinical manifestations of hyperandrogenism include presence of acne, hirsutism, and androgenic alopecia); (3) polycystic ovaries by ultrasound examination: presence of 12 or more follicles in each ovary measuring 2-9 mm on diameter and/or ovarian volume>10 ml.
  • Age between 14 and 40 years.
  • 2 years after menarche

排除标准

  • Administration of other medications known to affect reproductive function or metabolism within the past three months, including oral contraceptives, Gonadotropin-releasing hormone (GnRH) agonists and antagonists, anti androgens, gonadotropins, anti-obesity drugs, Chinese herbal medicines, anti diabetic drugs such as metformin and thiazolidinediones, somatostatin, diazoxide, and calcium channel blockers.
  • Patients with other endocrine disorders including 21-hydroxylase deficiency, hyperprolactinemia, uncorrected thyroid disease, suspected Cushing's syndrome.
  • Patients with known severe organ dysfunction or mental illness.

研究组 & 干预措施

Chinese Medicine Formula

Experimental

All 100 patients were treated with Chinese Medicine Formula(CMF) for three menstrual cycles.

干预措施: Chinese Medicine Formula (Drug)

结局指标

主要结局

The fatty acid amides (FAAs) metabolite changes

时间窗: 3 months

The metabolic changes before and after treatment

次要结局

  • The sulfated steroids metabolite changes(3 months)

研究者

发起方
Heilongjiang University of Chinese Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yan Li

Clinical professor

Heilongjiang University of Chinese Medicine

研究点 (1)

Loading locations...

相似试验